Pain Management Drugs Market by Market Trends, Active Modernization in Technology in the Forecast period (2021 to 2027) with COVID-19 Study

Global Pain Management Drugs Market 

Pain management drugs are defined as specific drug classes that have pharmacological actions on pain receptors & work against the pain symptoms. These drugs can be used for pain management of conditions, as indicated on label & some drugs have off-label uses. For example, antidepressants & anticonvulsants were originally used for the management of depression & epilepsy respectively. However, these drugs have shown activity against pain indications & are prescribed for pain management as off-label indication.

Growing geriatric population is the main factor which drives global pain management drugs market growth, as geriatric people are more to suffer from joint as well as other chronic conditions. Also, the increase in prevalence of chronic diseases like diabetes, cancer, and osteoarthritis will positively influence the market growth. In addition, the increase in number of surgical procedures and growing healthcare expenditure are expected to propel the global pain management drugs market growth.

Get Request Sample copy @ https://qualiketresearch.com/request-sample/Pain-Management-Drugs-Market/request-sample

Furthermore, lack of alternative treatment therapies is expected to boost the target market growth throughout the forecast period. For instance, in 2015, Depomed, Inc. has acquired the United States rights to NUCYNTA ER (tapentadol), NUCYNTA (tapentadol), extended-release tablets & NUCYNTA (tapentadol) oral solution from Janssen Pharmaceuticals, Tapentadol is available in solution, tablet, and extended-release forms. Moreover, the solution & tablet forms of NUCYNTA have three patents, out of which one expired in the June 2017 and remaining two will expire in June 2025 & August 2029, respectively. Moreover, patent expiry of pain management drugs like Oxycontin, Opana, Celebrex (2013 – 2014), and others are creating opportunity to key players for introducing new products in the market.

Life threatening side effects associated with pain management medications & addiction issues with opioid drugs are expected to hamper the global pain management drugs market growth over the forecast period. Also, lack of research and development activities by major players are anticipated to hinder global pain management market growth.

Impact of COVID-19

The COVID-19 crisis is expected to impact the pain management drugs market in the initial phase of over the forecast period. The pandemic has stressed healthcare systems across the globe, so many clinics & pain services are no longer open for public services, due to safety measures imposed by governments. Also, during the latter half of the forecast period, demand for pain management drugs is expected to increase, owing to numerous factors including telemedicine, which is an appropriate & effective way to provide necessary medical services to patients with chronic pain.

Market Segmentation

The global pain management market is segmented into pain type such as Acute, and Chronic, by drug class such as NSAIDs, Anticonvulsants, Anesthetics, Antidepressants, Anti-migraine Agents, Opioids, and Nonnarcotic Analgesics. Further, market is segmented into indication such as Arthritic Pain, Neuropathic Pain, Chronic Back Pain, Postoperative Pain, Migraine, Muscle sprain/strain, Acute appendicitis, and Others.

Also, the Global Pain Management Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Regional Analysis

The North America region accounted for majority of pain management drug market share in the year 2019, and it is anticipated to remain dominant over the forecast period. Due to the increase in geriatric population and favorable regulatory conditions. The increase in number of drug abuse cases & additive nature of opioid has reduced use of prescriptions for opioid in the region. Moreover, the APAC region is expected to experience highest growth rate throughout the forecast period, due to presence of larger patient pool and the rise in healthcare experience in the region.

Market Key Players

Various key operating players are listed in this report such as Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions, Inc., Pfizer, Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., Purdue Pharma L.P., Mylan NV., etc.

Market Taxonomy

By Pain Type

  • Acute
  • Chronic

By Drug Class

  • NSAIDs
  • Anticonvulsants
  • Anesthetics
  • Antidepressants
  • Anti-migraine Agents
  • Opioids
  • Nonnarcotic Analgesics

By Indication

  • Arthritic Pain
  • Neuropathic Pain
  • Chronic Back Pain
  • Postoperative Pain
  • Migraine
  • Muscle sprain/strain
  • Acute appendicitis
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Browse full report @ https://qualiketresearch.com/reports-details/Pain-Management-Drugs-Market

About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which help our clients outperform their competition.

Contact Person:

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A

Email: sales@qualiketresearch.com

Website: https://qualiketresearch.com

 

Related Articles

Back to top button